German HTA Negative On Benefits Of First Ever Peanut Allergy Treatment
The decision by IQWiG could have an impact on how Palforzia is priced if the findings are upheld.
You may also be interested in...
Aimmune Therapeutics secures agreement with NHS for “step change” in treating peanut allergy.
Without further work, the EU-wide joint clinical assessments introduced by the EU regulation on health technology assessments will fail to meet the needs of advanced therapies, warns the Alliance for Regenerative Medicine.
IMC, the R&D-based pharmaceutical industry association in Canada, says the guideline will “exacerbate an already unpredictable regulatory environment.”